date:Apr 14, 2014
ion of FSMA, Taylor said that FDA is planning to address the issue in the next round of comments on revised rule language to be released this summer.
As to the timing of those rereleases, Taylor said that, while the agency has been aiming for June, Thats ambitious. Were going to work hard to get it done as soon as we can so that we meet our court-ordered deadlines for the final rules.
As for the strategic direction document he mentioned while responding to the question about economically motiv